TrialThe journal of prevention of Alzheimer's disease2026

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease.

James W Kupiec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.